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Abstract Insight into echocardiographic parameters in
the general population may facilitate early recognition of
ventricular dysfunction, reducing the population morbidity
and mortality of heart failure. We examined the distribution
of structural, systolic and diastolic echocardiographic
parameters and their associations with cardiovascular risk
factors in the Rotterdam Study, a population-based cohort
study in men and women aged C55 years. Participants with
prevalent heart failure, myocardial infarction and atrial
ﬁbrillation and ﬂutter were excluded. Echocardiographic
parameters were assessed using two-dimensional, M-mode
and Doppler echocardiography. Echocardiograms were
available in 4,425 participants. Structural parameters were
generally larger in men, and most consistently associated
with age, body mass index and blood pressure in both sexes.
Prevalence of moderate or poor left ventricular systolic
function was 3.9% in men and 2.1% in women. Age, body
mass index and blood pressure were most consistently
associated with systolic function. E/A ratio was lower in
women than in men. Age and diastolic blood pressure were
most consistently associated with E/A ratio in both sexes. In
conclusion, ventricular systolic and diastolic dysfunction is
present in asymptomatic individuals. Selected established
cardiovascular risk factors are associated with structural,
systolic and diastolic parameters.
Keywords Cardiovascular disease  Diastolic function 
Echocardiography  Systolic function
Abbreviations
ACE Angiotensin converting enzyme
BMI Body mass index
ECG Electrocardiogram
GP General practitioner
HDL High-density lipoprotein
IVST Interventricular septum thickness
LVED Left ventricular end diastolic dimension
LVES Left ventricular end systolic dimension
PWT Posterior wall thickness
Introduction
Heart failure is an important health problem. Its prevalence
is increasing, in part because of improved treatment of
patients with heart failure and increased survival of patients
with myocardial infarction [1]. Since heart failure is pri-
marily a condition in the elderly, the aging of the popula-
tion also contributes to its increasing prevalence. Although
in most patients, abnormalities of systolic and diastolic
dysfunction coexist [1], it has been shown that persons with
normal ejection fraction can have impaired diastolic
function [2]. Also of note is, that persons with a very low
ejection fraction may be asymptomatic; this has been
termed preclinical systolic dysfunction [3].
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DOI 10.1007/s10654-010-9453-5It has been recognized that therapeutic interventions
introduced even before the appearance of left ventricular
dysfunction or symptoms can reduce the population mor-
bidity and mortality of heart failure [1, 4]. This underlines
the importance of early recognition of preclinical ventric-
ular dysfunction. Echocardiography, which has become a
common method to assess ventricular function, may be
useful to gain more insight into this matter. To its advan-
tage, it is noninvasive and comprehensive. As a conse-
quence, echocardiography has been used in several
population-based studies to examine the prevalence and
determinants of systolic and diastolic dysfunction in the
community [3, 5–9] and to investigate the predictive value
of echocardiographic parameters for heart failure, cardio-
vascular disease and mortality [3, 7, 10–13].
The growing importance of insight into echocardio-
graphic characteristics of the general population has
prompted us to perform echocardiography in the Rotterdam
Study, a population-based study in men and women aged
55 years and over. The purpose of the present report is to
describe the distribution of structural, systolic and diastolic
echocardiographic parameters in our study population and
to examine the associations of established cardiovascular
risk factors with these echocardiographic parameters.
Methods
Study population
The study was performed within the framework of the
Rotterdam Study, a population-based cohort study aimed at
assessing the occurrence of and risk factors for chronic
diseases in the elderly [14]. Baseline visits of the Rotterdam
Study took place in 1990–1993. All inhabitants of a suburb
of Rotterdam aged 55 years and over were invited and
7,983 agreed to participate (response 78%). Follow-up
visits took place in 1993–1994 and 1997–1999. In 2000–
2001, the cohort was extended with 3,011 participants from
the same suburb (response 67%), also aged 55 years and
over. For the present study, data collection took place from
2002–2005. Within this period, the participants from the
original cohort completed their fourth center visit
(n = 3,550), and the participants of the extended cohort
completed their second center visit (n = 2,389). Of these,
3,052 and 2,235, respectively, underwent cardiac echocar-
diography. The large majority of missing echocardiograms
was explained by incidental absence of echocardiographers.
Participants with prevalent heart failure (n = 304), pre-
valent myocardial infarction, (n = 561), and atrial ﬁbrilla-
tion (n = 124) or atrial ﬂutter (n = 13) at the time of
echocardiography were excluded from the analysis. This led
to the exclusion of a total of 862 persons and consequently
resulted in a total of 4,425 participants available for anal-
ysis. The medical ethics committee of Erasmus Medical
Center, Rotterdam, approved the study. Participants gave
written informed consent and permission to retrieve infor-
mation from treating physicians. The investigation con-
forms with the principles outlined in the declaration of
Helsinki.
Assessment of cardiovascular risk factors
and prevalent disease
A trained interviewer visited all participants at home and
collected information on current health status, medical his-
tory, drug use, and smoking, using a computerized ques-
tionnaire. Participants were categorized as current, past and
never smokers. Clinical measures were obtained during a
visit at the study center. Height and weight were measured
andthe bodymass index(BMI)wascalculated (weight (kg)/
height (m)
2). Blood pressure was measured at the right
brachial artery using a random-zero sphygmomanometer
with the participant in sitting position. Serum total choles-
terol and high-density lipoprotein (HDL) cholesterol were
obtained using an automatic enzymatic procedure (Hitachi
911, Roche CHOD PAP). Diabetes mellitus was deﬁned as
the use of antidiabetic medication or a fasting glucose level
of C7 mmol/l [15]. Presence of symptomatic heart failure at
the time of echocardiography was assessed by using a val-
idated score similar to the deﬁnition of heart failure of the
European Society of Cardiology, as described previously
[16], and the information needed was obtained by screening
of all medical records of general practitioners (GPs) in ret-
rospect for the occurrence of heart failure and obtaining
lettersanddischargereportsfrommedicalspecialistswhena
case was found. A history of myocardial infarction was
consideredpresentwhenmyocardialinfarctionwasdetected
by screening GP medical records and reviewing letters and
discharge reports from medical specialists, or when an ECG
characteristic of prior myocardial infarction was detected
during a follow-up visit. Presence of atrial ﬁbrillation or
atrial ﬂutter at the time of echocardiography was assessed
with electrocardiography by applying the Modular ECG
Analysis System (MEANS), which has been extensively
evaluated [17, 18], and is characterized by a high sensitivity
(96.6%) and a high speciﬁcity (99.5%) in coding arrhyth-
mias[19].Forasmallsampleofparticipants,ECGswerenot
available at the time this report was written because of
logistic problems and were approximated by using ECGs
from the previous examination (year 2000–2001).
Echocardiography
For each participant, an echocardiogram was obtained. The
ﬁrst 2,188 echocardiograms were performed with a
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123commercially available ultrasonography system (AU3
Partner, Esaote Biomedica, with a 3.5/2.5 MHz trans-
ducer). The following 3,099 echocardiograms were per-
formed with another commercially available system
(Acuson Cypress, with a 3V2c transducer). A standardized
protocol was used, including two-dimensional scanning in
the parasternal long axis view, parasternal short axis view,
apical view and subcostal view, M-mode scanning in the
parasternal long axis view, and pulsed wave Doppler
scanning in the apical four chamber view [20]. Echocar-
diograms were recorded onto VHS tape and assessed at the
reading center, which was located at Erasmus Medical
Center.
Several structural parameters were assessed [21]. Left
atrium diameter, left ventricular end systolic dimension
(LVES), left ventricular end diastolic dimension (LVED),
end diastolic interventricular septum thickness (IVST) and
end-diastolic left ventricular posterior wall thickness
(PWT) were measured in the parasternal long axis view
using M-mode with two-dimensional guidance. Left ven-
tricular mass (grams) was calculated as 0.80(1.04*
(IVST ? LVED ? PWT)
3-(LVED)
3) ? 0.6, according to
Devereux et al [22]. Fractional shortening at the endocar-
dium was calculated as (LVED-LVES)/LVED*100% [21].
Global left ventricular systolic function was qualitatively
assessed, without quantitative measurement, from the two-
dimensional echocardiogram and classiﬁed as normal, fair,
moderate or poor. Furthermore, diastolic parameters were
measured [23]. Pulsed Doppler recordings of transmitral
ﬁlling velocity were performed in the apical 4-chamber
view, with the sample volume placed in the mitral valve
oriﬁce near the tips of the leaﬂets. Doppler peak E and peak
A velocities were averaged over three cycles. E/A ratio was
computed by dividing Doppler peak E velocity by Doppler
peak A velocity. Early mitral valve velocity deceleration
time was measured as the time between the peak E wave
and the upper deceleration slope extrapolated to the zero
baseline.
Echocardiograms were made and read by four trained
echocardiographers. To assess intra-reader and inter-reader
agreement, 32 participants were examined in duplicate. For
continuous variables, overall median percent intra-reader
and inter-reader measurement variabilities were calculated
as the absolute measurement difference divided by the
average of the two measurements, multiplied by 100.
Overall median intra-reader and inter-reader variabilities
for left ventricular end-diastolic dimension were 3 and 4%,
respectively. For left ventricular end-systolic dimension
both variabilities were 6%, and for fractional shortening
both were 8%. Overall median intra-reader and inter-reader
variabilities for E/A ratio were 15 and 18%, respectively,
and for deceleration time both were 16%. Finally, the
percentage agreement for categorization of left ventricular
systolic function as normal or other than normal was 82%
within readers and 86% between readers.
Statistical analysis
We calculated means, medians and proportions of cardio-
vascular risk factors and echocardiographic characteristics
in men and women. Differences between the sexes were
tested with t-tests, chi square tests and Mann–Whitney tests
where appropriate.
Subsequently, we investigated the association between
cardiovascular risk factors and echocardiographic param-
eters. We performed linear regressions with age, BMI,
systolic blood pressure, diastolic blood pressure, total cho-
lesterol, HDL-cholesterol, diabetes mellitus and smoking
as independent variables and structural echocardiographic
parameters (diameter of left atrium, left ventricular end-
systolic dimension, left ventricular end-diastolic dimension,
interventricular septum thickness, left ventricular posterior
wall thickness, left ventricular mass), systolic parameters
(ejection fraction, fractional shortening) and diastolic
parameters(mitralvalveinﬂowpeakEvelocity,mitralvalve
inﬂow peak A velocity, E/A ratio and mitral valve inﬂow
deceleration time) as dependent variables. Continuous
independentvariableswereexaminedperstandarddeviation
increase. For some of the dependent variables, the distri-
butionoftheresidualswasskewed.Afterlog-transformation
of these variables, the residuals were normally distributed
withaconstantvariance.Tomaketheregressioncoefﬁcients
more informative, units of dependent variables were multi-
pliedby10
-2.Theanalysiswasperformedseparatelyinmen
and women. We adjusted for age and type of ultrasonogra-
phy system used, and subsequently, we also adjusted the
analysis of each risk factor for all other risk factors and also
for use of diuretics, beta-blockers, ACE inhibitors, lipid
lowering drugs and heart rate.
We used analysis of covariance to compare risk factors,
structural echocardiographic parameters, and fractional
shortening according to categories of qualitatively assessed
left ventricular systolic function and categories of E/A ratio
and diastolic function. Few men and women had poor left
ventricular systolic function (n = 19 and n = 10, respec-
tively), therefore we pooled moderate and poor systolic
function for the analysis to make the results easier to
interpret. We categorized E/A ratio according to cut points
used in previous reports [3, 24].
All analyses were performed using SPSS 11.0. Values
for cardiovascular covariates were missing in less than 3%
of participants, except for BMI, which was missing in 5.5%.
Missing values were handled by single imputation using the
expectation-maximization algorithm in SPSS 11.0. All tests
were two-sided. We ran several analyses in duplicate to
compare the two ultrasonography systems we used.
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123Results
Table 1 shows the distribution of cardiovascular risk fac-
tors in men and women. Women were signiﬁcantly older
than men, although this was a clinically modest difference
of 1.1 years. In Table 2, the distribution of echocardio-
graphic characteristics is displayed in men and women. All
characteristics showed signiﬁcant differences across the
sexes; in general, structural parameters were larger in men,
systolic function was worse in men, and with regard to
diastolic function, E/A ratio was lower in women.
For reasons of conciseness, only the multivariable
results are presented. Overall, age, BMI, systolic blood
pressure and diastolic blood pressure were signiﬁcantly
associated with most structural parameters in men and
women (Supplementary Table 1). Age, BMI and systolic
Table 1 Population
characteristics
Categorical variables are
expressed as percentage.
Continuous variables are
expressed as mean ± standard
deviation. T-tests and chi square
tests were used where
appropriate
Variable Men (n = 1,736) Women (n = 2,689) P-value
Age (years) 70.8 ± 7.0 71.9 ± 7.5 \0.001
Body mass index (kg/m
2) 27.2 ± 3.4 27.7 ± 4.5 \0.001
Systolic blood pressure (mmHg) 148 ± 20 151 ± 22 \0.001
Diastolic blood pressure (mmHg) 81 ± 11 79 ± 11 \0.001
Total cholesterol (mmol/l) 5.4 ± 0.9 5.9 ± 0.9 \0.001
HDL-cholesterol (mmol/l) 1.3 ± 0.3 1.6 ± 0.4 \0.001
Diabetes mellitus (%) 13.4 12.7 0.49
Smoking
Never (%) 13.4 43.1 \0.001
Former (%) 68.2 42.8
Current (%) 18.4 14.0
Use of diuretics (%) 5.4 11.8 \0.001
Use of beta blockers (%) 11.9 15.6 \0.001
Use of ACE-inhibitors (%) 11.2 11.0 0.79
Use of lipid-lowering drugs (%) 11.2 11.9 0.52
Table 2 Echocardiographic characteristics
Variable Men (n = 1,736) Women (n = 2,689) P-value
Structural parameters
Left atrium diameter (mm) 42 ± 53 9 ± 5 \0.001
Left ventricular end systolic dimension (mm) 32 (29–36)
a 29 (27–32)
a \0.001
Left ventricular end diastolic dimension (mm) 53 ± 54 9 ± 5 \0.001
Interventricular septum thickness (mm) 8 (8–10)
a 8 (7–9)
a \0.001
Left ventricular posterior wall thickness (mm) 8 (7–8)
a 7 (7–8)
a \0.001
Left ventricular mass (g) 157 (135–187)
a 130 (110–151)
a \0.001
Systolic parameters
Ejection fraction (%) 0.77 (0.71–0.82)
a 0.79 (0.74–0.83)
a \0.001
Fractional shortening (%) 38 ± 74 0 ± 6 \0.001
Left ventricular systolic function (qualitative)
Normal (%) 55.0 64.9 \0.001
Fair (%) 41.0 33.1
Moderate or poor (%) 3.9 2.1
Diastolic parameters
Mitral valve inﬂow peak E (m/s) 0.63 ± 0.15 0.66 ± 0.16 \0.001
Mitral valve inﬂow peak A (m/s) 0.72 ± 0.16 0.80 ± 0.17 \0.001
Mitral valve inﬂow deceleration time (ms) 219 ± 47 211 ± 45 \0.001
E/A ratio 0.86 (0.71–1.00)
a 0.81 (0.70–1.00)
a \0.001
Categorical variables are expressed as percentage. Continuous variables are expressed as mean ± standard deviation. T-tests, chi square tests and
Mann–Whitney tests were used where appropriate
a Median and inter-quartile range because of skewed distribution
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123blood pressure generally showed positive associations,
with the exception of an inverse association of age with left
ventricular end diastolic dimension in women. Diastolic
blood pressure showed inverse associations with left atrium
diameter in men and women. Furthermore, total cholesterol
showed associations with selected parameters (Supple-
mentary Table 1). The age- and ultrasonography system
adjusted results (data not shown) demonstrated additional
associations between HDL-cholesterol and diabetes melli-
tus and most structural parameters (inverse and positive
associations, respectively), which disappeared after further
adjustment.
In Table 3, multivariable-adjusted associations with
fractional shortening are displayed. Age, BMI and diastolic
blood pressure showed inverse associations with fractional
shortening, while systolic blood pressure showed positive
associations. In men, the association of systolic blood
pressure with fractional shortening did not reach statistical
signiﬁcance. However, the magnitude of the regression
coefﬁcient was comparable to that of the signiﬁcant
regression coefﬁcient in women. The results were similar
when models were adjusted for age- and ultrasonography
systemonly(datanotshown).Table 4showsassociationsof
risk factors with left ventricular systolic function. Overall,
the results were in accordance with Table 3. Age was higher
in men and women with fair and moderate/poor function
than in those with normal function. BMI was also signiﬁ-
cantly higher in men and women with fair function. Sys-
tolic blood pressure was lower in men with fair function
than in men with normal function. In women, systolic blood
pressure decreased and diastolic blood pressure increased
according to systolic function categories. In Table 5, struc-
tural echocardiographic parameters are displayed according
to categories of left ventricular systolic function. In general,
left ventricular end-systolic and end-diastolic dimensions
increased with worsening systolic function, as did inter-
ventricular septum thickness, left ventricular posterior wall
thickness and left ventricular mass. As expected, fractional
shortening signiﬁcantly decreased with worse qualitative
systolic function.
Subsequently associations between cardiovascular risk
factors and diastolic echocardiographic parameters were
examined. Age and diastolic blood pressure were inversely
and signiﬁcantly associated with E/A ratio in men and
Table 3 Multivariable adjusted regression coefﬁcients for risk fac-
tors, describing the increase in fractional shortening (% *10
-2) per
(sex-speciﬁc) standard deviation increase of the risk factors
Variable Fractional shortening (% *10
-2)
Men
Age (years) -125 (-163, -87.1)

Body mass index (kg/m
2) -39.4 (-74.4, -4.34)*
Systolic blood pressure (mmHg) 34.3 (-4.94, 73.6)
Diastolic blood pressure (mmHg) -54.3 (-93.9, -14.6)

Total cholesterol (mmol/l) 6.11 (-27.7, 39.9)
HDL-cholesterol (mmol/l) 20.0 (-14.0, 53.9)
Diabetes mellitus -51.8 (-148.6, 45.0)
Current smoking -41.8 (-124, 40.6)
Women
Age (years) -77.5 (-106, -49.6)

Body mass index (kg/m
2) -26.1 (-52.0, -0.13)*
Systolic blood pressure (mmHg) 36.4 (5.52, 67.3)*
Diastolic blood pressure (mmHg) -47.6 (-77.3, -17.8)

Total cholesterol (mmol/l) 10.3 (-14.3, 34.9)
HDL-cholesterol (mmol/l) 3.59 (-21.2, 28.3)
Diabetes mellitus 9.65 (-63.1, 82.4)
Current smoking -32.9 (-99.5, 33.7)
All models are adjusted (where appropriate) for ultrasonography
system, age, BMI, systolic and diastolic blood pressure, total and
HDL cholesterol, diabetes mellitus, smoking, use of diuretics, beta-
blockers, ACE inhibitors, lipid lowering drugs and heart rate
* 0.01\P\0.05,
 0.001\P\0.01,
 P\0.001
Table 4 Population characteristics according to left ventricular sys-
tolic function, multivariable adjusted
Variable Left ventricular systolic function
Normal Fair Moderate/
poor
Men n = 938 n = 699 n = 67
Age (years) 69.7 72.0
 73.1

Body mass index (kg/m
2) 26.9 27.5
 26.9
Systolic blood pressure (mmHg) 149 147* 146
Diastolic blood pressure (mmHg) 81 82 82
Total cholesterol (mmol/l) 5.4 5.4 5.4
HDL-cholesterol (mmol/l) 1.33 1.31 1.32
Diabetes mellitus (%) 13.0 12.3 21.2
Current smoking (%) 16.6 21.1* 15.5
Women n = 1,725 n = 879 n = 54
Age (years) 70.8 73.5
 75.5

Body mass index (kg/m
2) 27.5 28.1
 27.7
Systolic blood pressure (mmHg) 152 150
 143

Diastolic blood pressure (mmHg) 79 80
 81*
Total cholesterol (mmol/l) 5.9 5.9 5.6

HDL-cholesterol (mmol/l) 1.58 1.57 1.51
Diabetes mellitus (%) 11.9 14.0 7.4
Current smoking (%) 13.8 14.8 20.1
All models are adjusted (where appropriate) for ultrasonography
system, age, BMI, systolic and diastolic blood pressure, total and
HDL cholesterol, diabetes mellitus, smoking, use of diuretics, beta-
blockers, ACE inhibitors, lipid lowering drugs and heart rat
* 0.01\P\0.05,
 0.001\P\0.01,
 P\0.001, compared to
normal left ventricular systolic function
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123women, whereas systolic blood pressure showed no asso-
ciation (Supplementary Table 2). BMI was positively and
signiﬁcantly associated with E/A ratio in women; in men,
the regression coefﬁcient was of similar magnitude but
did not reach signiﬁcance. Age- and ultrasonography sys-
tem adjusted analyses also showed inverse associations
between BMI and systolic blood pressure and E/A ratio in
both sexes; however, these did not persist after additional
adjustment. Categorization of E/A ratio conﬁrmed the
associations of lower E/A ratio with higher age and dia-
stolic blood pressure in both sexes (Table 6). Of note is that
it also showed signiﬁcantly lower systolic blood pressure in
women with E/A ratio\0.75.
All above-mentioned analyses were adjusted for ultra-
sonography system to account for any possible differences.
When running analyses in duplicate using the two systems
separately, the associations were similar in direction and
magnitude, but were more likely to reach statistical signif-
icance using the Acuson system.
Discussion
Summarizing, in this study, we have examined structural,
systolic and diastolic echocardiographic parameters and
their associations with cardiovascular risk factors in a
population-based cohort. Structural parameters were gen-
erally larger in men, and larger values were most consis-
tently associated with higher values of age, BMI and
systolic blood pressure in both sexes. Although we had
excluded participants with prevalent heart failure, myo-
cardial infarction, and atrial ﬁbrillation and ﬂutter, mod-
erate or poor left ventricular systolic function was found to
be present in the participants, albeit with a modest preva-
lence (a total of 3.9% of men and 2.1% of women). Higher
age, higher BMI, lower systolic and higher diastolic blood
pressure were most consistently associated with worse
systolic function. Furthermore, persons with worse systolic
function had larger ventricular dimensions and larger left
ventricular mass. With regard to diastolic parameters, we
found that Doppler peak E and peak A velocities were
larger in women than in men, but that E/A ratio was lower
in women than in men. Higher age and higher diastolic
blood pressure were most consistently associated with
lower E/A ratio in both sexes.
Strengths of the present study include its population-
based nature, its large size, and its standardized assessment
of risk factors and echocardiographic characteristics. Nev-
ertheless,severalissueswarrantconsideration.First,weused
global left ventricular function assessed qualitatively from
two-dimensional images. This approach is easily obtainable
and reﬂects the routine procedure in echocardiography
Table 5 Structural echocardiographic parameters and fractional shortening according to left ventricular systolic function, multivariable adjusted
Variable Left ventricular systolic function
Normal Fair Moderate/ poor
Men n = 938 n = 699 n = 67
Diameter of left atrium (mm) 42 42 43
Left ventricular end-systolic dimension (mm)
§ 30 35
 43

Left ventricular end-diastolic dimension (mm) 52 54
 59

Interventricular septum thickness (mm)
§ 8.7 8.4
 8.3
Left ventricular posterior wall thickness (mm)
§ 7.9 7.5
 7.9
Left ventricular mass (g)
§ 157 159 190

Fractional shortening (%) 42 35
 25

Women n = 1,725 n = 879 n = 54
Diameter of left atrium (mm) 39 39 40*
Left ventricular end-systolic dimension (mm)
§ 28 32
 40

Left ventricular end-diastolic dimension (mm) 49 50
 55

Interventricular septum thickness (mm)
§ 8.1 8.0 8.1
Left ventricular posterior wall thickness (mm)
§ 7.3 7.2
 7.8

Left ventricular mass (g)
§ 129 130 165

Fractional shortening (%) 42 36
 26

All models are adjusted for ultrasonography system, age, BMI, systolic and diastolic blood pressure, total and HDL cholesterol, diabetes mellitus,
smoking, use of diuretics, beta-blockers, ACE inhibitors, lipid lowering drugs and heart rate
* 0.01\P\0.05,
 0.001\P\0.01,
 P\0.001, compared to normal left ventricular systolic function
§ Geometric mean because of skewed distribution
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123laboratories. Prior studies have reported that the reproduc-
ibility and accuracy of visual assessments are as good as
those of quantitative methods [25, 26], and similar visual
assessments have also been used in other studies such as the
Framingham Study [13]. Associations of risk factors with
qualitative left ventricular function and with quantitatively
measured fractional shortening showed similar patterns, and
this suggest that assessment of left ventricular systolic
function was performed appropriately in our study.
Second, we used E/A ratio as an indicator of diastolic
function, while measures such as pulmonary venous ﬂow or
Doppler tissue imaging are needed to further categorize
diastolic function [27, 28]. We were not able to assess such
additional measures because of constraints in examination
time available per participant, inherent to large-scale pop-
ulation-based research. Several different recommendations
have been issued for categorization of diastolic function
based on E/A ratio [29, 30]. E/A ratio is usually categorized
according to absolute cut-points based on its physiology.
We based our categorization of E/A ratio on absolute cut-
points used in recent reports [3, 24].
Furthermore, we should bear in mind that some of
the echocardiographic measurements displayed consider-
able variability. Inter-reader and intra-reader measurement
variabilities for E/A ratio and deceleration time reﬂect the
practical difﬁculties involved in estimating Doppler peak E
velocity and Doppler peak A velocity. In contrast, intra-
reader and inter-reader variability of structural and systolic
parameters was in a much lower range. Finally, when
analyzing the Esaote and Acuson ultrasonography systems
separately, similar results were found, but associations
were more likely to reach statistical signiﬁcance in the
group where the Acuson system was used. Higher numbers
of participants in the Acuson group may partly explain this.
However, precision may have also played a part, since the
Acuson system provided images of somewhat better reso-
lution. In the latter case, the associations we found may in
reality be even stronger.
Previously, fractional shortening has been measured in a
subset of 2,267 participants of the Rotterdam Study [31]. In
accordance with the present study, fractional shortening
was found to be somewhat higher in women (40 ± 7%)
than in men (38 ± 8%). However, no signiﬁcant associa-
tion was found with age.
In the present study, women on average had better left
ventricular systolic function than men, and E/A ratio was
found to be lower in women. This is in accordance with
known gender differences in heart failure; systolic dys-
function is more common in men and diastolic dysfunction
tends to occur more often in women. This is explained by
Table 6 Population characteristics according to E/A ratio, multivariable adjusted
Variable E/A ratio
E/A\0.75 0.75 B E/A B 1.50 E/A[1.50
Men n = 457 (27.4%) n = 1,183 (70.9%) n = 29 (1.7%)
Age (years) 73.5
 69.7 69.2
Body mass index (kg/m
2) 27.2 27.2 27.2
Systolic blood pressure (mmHg) 147 148 149
Diastolic blood pressure (mmHg) 82
 81 80
Total cholesterol (mmol/l) 5.4 5.4 5.2
HDL-cholesterol (mmol/l) 1.31 1.32 1.33
Diabetes mellitus (%) 14.7 12.1 16.0
Current smoking (%) 29.9 18.0 11.3
Women n = 824 (31.8%) n = 1,730 (70.9%) n = 36 (1.4%)
Age (years) 74.6
 70.4 69.7
Body mass index (kg/m
2) 27.9 27.6 26.9
Systolic blood pressure (mmHg) 149
 151 152
Diastolic blood pressure (mmHg) 81
 79 77
Total cholesterol (mmol/l) 6.0 5.9 5.7
HDL-cholesterol (mmol/l) 1.55* 1.59 1.59
Diabetes mellitus (%) 11.6 12.6 21.9
Current smoking (%) 14.6 14.4 13.0
All models are adjusted (where appropriate) for ultrasonography system, age, BMI, systolic and diastolic blood pressure, total and HDL
cholesterol, diabetes mellitus, smoking, use of diuretics, beta-blockers, ACE inhibitors, lipid lowering drugs and heart rate
* 0.01\P\0.05,
0.001\P\0.01,
 P\0.001, compared to 0.75 B E/A B 1.50
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123the fact that men have coronary artery disease as an
underlying factor for heart failure more frequently than
women, while women are more likely to have hypertension
as an underlying factor [32, 33]. Heart failure that occurs
after myocardial infarction is characterized by profound
ventricular dilation, wall thinning, increased heart size,
eccentric hypertrophy and systolic dysfunction. Heart
failure that occurs due to long-standing hypertension is
characterized by (concentric) left ventricular hypertrophy,
increased myocardial mass and diastolic dysfunction,
especially in the early stages.
The distribution of echocardiographic parameters and
their associations with cardiovascular risk factors have
previously been examined in several population-based
studies. Table 7 provides an overview of the main ﬁndings
of several large studies and compares them to the current
study. It shows that prevalence of systolic and diastolic
dysfunction varies across studies, probably in part due to
differences in population characteristics and deﬁnitions of
ventricular dysfunction. Nevertheless, associations of age,
sex, and blood pressure with ventricular dysfunction appear
to be rather consistent across studies.
In conclusion, we have found that moderate and poor
left ventricular systolic function was present in asymp-
tomatic men and women participating in the Rotterdam
Study. With regard to diastolic parameters, we found that
E/A ratio was on average lower in women than in men.
Higher age, BMI and diastolic blood pressure and lower
systolic blood pressure were most consistently associated
with worse systolic function in both sexes. Higher age and
diastolic blood pressure were most consistently associated
with lower E/A ratio in both sexes. Further research is
warranted to investigate the value of echocardiography in
identiﬁcation of individuals with preclinical ventricular
dysfunction.
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